🇺🇸 FDA
Patent

US 11359204

Chimeric antigen receptors targeting B-cell maturation antigen

granted A61KA61K2039/505A61K48/00

Quick answer

US patent 11359204 (Chimeric antigen receptors targeting B-cell maturation antigen) held by THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K2039/505, A61K48/00, A61P, A61P35/00